Document is current
Any future updates will be listed below
-
Authors
Zhao, Chenkai https://orcid.org/0000-0002-0962-2741
Zhang, Tiantian
Guo, Ling
Sun, Shiqi
Miao, Yumeng
Yung, Chee Fu
Tomlinson, Jane
Stolyarov, Kirill
Shchomak, Zakhar
Poovorawan, Yong
Nokes, David James https://orcid.org/0000-0001-5426-1984
Muñoz-Almagro, Carmen https://orcid.org/0000-0001-5586-404X
Mandelboim, Michal
Keck, James W.
Langley, Joanne Marie https://orcid.org/0000-0003-3270-7345
Heikkinen, Terho
Deng, Jikui
Colson, Philippe https://orcid.org/0000-0001-6285-0308
Chakhunashvili, Giorgi
Caballero, Mauricio T.
Bont, Louis https://orcid.org/0000-0003-3099-4475
Feikin, Daniel R. https://orcid.org/0000-0001-5154-5084
Nair, Harish https://orcid.org/0000-0002-9432-9100
Wang, Xin https://orcid.org/0000-0002-8762-2421
Li, You https://orcid.org/0000-0002-8506-8439
,
Abo, Yara-Natalie
Daley, Andrew
Waller, Gregory
Danilenko, Daria M.
Komissarov, Andrey B.
Bandeira, Teresa
Barreto, Maria Rosário
Suntronwong, Nongruthai
Pasittungkul, Siripat
Katama, Esther Nyadzua
Arranz, Alba
Launes, Cristian
Bassat, Quique
Nemet, Ital
Dobson, Jennifer D.
Bi, Jiajia
Deng, Guangcheng
Boschi, Céline
La Scola, Bernard
Raoult, Didier
Karseladze, Irakli
Zakhashvili, Khatuna
Tarkhan-Mouravi, Olgha
Dvorkin, Julia
Billard, Marie N.
-
Funding
Funding for this research was provided by:
World Health Organization
National Natural Science Foundation of China (82473692)
National Natural Science Foundation of China (82404372)
- License Information
-
More Information
Article History
Received: 16 September 2024
Accepted: 27 January 2025
First Online: 13 February 2025
Competing interests
: T.Z. reports personal fees from Pfizer, outside the submitted work. D.-J.N. reports grants from Wellcome Trust related to the submitted manuscript. C.M.-A. reports personal fees from MSD, Pfizer and Sanofi, and travel grants from MSD and Pfizer, outside the submitted work. J.-W.K. reports grants from Centers for Disease Control and Prevention (CDC) related to the submitted work, grants from National Institutes of Health, Merck Sharp and Dohme Corporation, United States Department of Agriculture, National Science Foundation, CDC and Greenwall Foundation, and participation on data safety monitoring boards for Enhancing the Diabetes Prevention Program to promote weight loss among non-responders in a community based lifestyle intervention funded by National Institute of Diabetes and Digestive and Kidney Diseases, outside the submitted work. J.-M.L. reports that her employer received grants for the conduct of clinical research from Pfizer, GSK, Sanofi, Merck, and Moderna and personal fees paid to her employer from Enanta, GSK and Sanofi. T.H. reports personal fees from MSD, Pfizer and Sanofi, and participation on data safety monitoring boards for Sanofi, Enanta, MSD, Moderna, Shionogi and Pfizer, outside the submitted work. H.N. reports grants from the Innovative Medicines Initiative, WHO, the National Institute for Health Research, Pfizer, and Icosavax; and personal fees from the Gates Foundation, Pfizer, ReViral, GSK, Merck, Icosavax, Sanofi, Novavax, and AbbVie, outside the submitted work. X.W reports grants from GSK and personal fees from Pfizer, outside the submitted work. Y.L. reports grants from WHO, the Wellcome Trust, and GSK, and personal fees from Pfizer, outside the submitted work. All other authors declare no competing interests.
